“…As we know, a prospective study has several advantages: more equilibrated randomized grouping, less confounding bias, and better comparability. A midterm prospective study was done by Ichijo et al [9] recently; it demonstrated that the LAARP had better postoperative clinical outcomes than PSARP for the treatment of high ARM, whereas patients had similar muscle mass size by radiologic analysis and similar white blood cell count that reflected surgical stress. However, in his work, the age at anorectoplasty was far older (8-9 months) than that in our study, and manometric methods were not used.…”